tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sandoz Expands Oncology Portfolio with Global License for Pertuzumab Biosimilar
PremiumCompany AnnouncementsSandoz Expands Oncology Portfolio with Global License for Pertuzumab Biosimilar
26d ago
Sandoz price target raised to CHF 60 from CHF 55 at JPMorgan
Premium
The Fly
Sandoz price target raised to CHF 60 from CHF 55 at JPMorgan
28d ago
Evotec to sell Just – Evotec Biologics EU, license technology to Sandoz
Premium
The Fly
Evotec to sell Just – Evotec Biologics EU, license technology to Sandoz
1M ago
Sandoz price target raised to CHF 55 from CHF 46 at JPMorgan
PremiumThe FlySandoz price target raised to CHF 55 from CHF 46 at JPMorgan
3M ago
Sandoz reaches agreement with Regeneron over patent litigation
Premium
The Fly
Sandoz reaches agreement with Regeneron over patent litigation
3M ago
Sandoz Resolves Patent Dispute, Paves Way for US Launch of Aflibercept Biosimilar
Premium
Company Announcements
Sandoz Resolves Patent Dispute, Paves Way for US Launch of Aflibercept Biosimilar
3M ago
Sandoz Advances Sustainability with New Solar Projects in Spain
PremiumCompany AnnouncementsSandoz Advances Sustainability with New Solar Projects in Spain
4M ago
Sandoz downgraded to Hold from Buy at Jefferies
Premium
The Fly
Sandoz downgraded to Hold from Buy at Jefferies
4M ago
Sandoz Group Ltd Reports Strong H1 2025 Results
Premium
Company Announcements
Sandoz Group Ltd Reports Strong H1 2025 Results
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100